In order to address this, we have used the A17 mouse model, widely employed for preclinical studies19, 20, 21 as it recapitulates some of the key features of OPMD such as muscle atrophy, PABPN1 aggregates and muscle fibrosis.22 Here, PABPN1 is linked to oculopharyngeal muscular dystrophy.